Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors [NA]
This trial update describes a longitudinal follow-up of lymphoma patients experiencing chemotherapy-induced peripheral neuropathy (CIPN) and…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H) [Phase 2]
Phase 2 MATCH subprotocol study evaluating copanlisib as a targeted treatment for cancers with PTEN expression. The trial is currently activ…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO [NA]
A completed clinical trial comparing an active psycho-social intervention at diagnosis with usual care to improve psychosocial support in AY…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U) [Phase 2]
Phase 2 MATCH subprotocol U update on defactinib (VS-6063) for cancers with NF2 genetic changes, with results posted and the trial listed as…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial of VIP-152 in combination with Venetoclax and Prednisone in relapsed/refractory lymphoid malignancies has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies [Phase 1]
This is a Phase 1 clinical trial update on CD22-directed CAR T cells for children and young adults with B-cell malignancies, including B-cel…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas [Phase 1, Phase 2]
A Phase 1/2 trial of brentuximab vedotin combined with BeEAM high-dose chemotherapy for lymphoma has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation [Phase 1]
A Phase 1 trial evaluating the efficacy of a generic plerixafor in autologous hematopoietic stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V) [Phase 2]
Phase 2 NCI MATCH subprotocol V is evaluating sunitinib for cancers with cKIT genetic alterations, including advanced and refractory lymphom…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. [Phase 1]
The SG2501 safety study in subjects with relapsed or refractory hematologic malignancies and lymphoma has been terminated (Phase 1).
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors [Phase 1]
Phase 1 clinical trial update of LP-284 in adults with relapsed or refractory lymphomas and advanced solid tumors, focusing on safety, pharm…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC) [NA]
The PHANTASTIC trial evaluating plerixafor-assisted, chemotherapy-free autologous stem cell transplantation for cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood [Phase 1]
Phase 1 trial update on infusing allogeneic CD19-specific T cells from peripheral blood for leukemia and lymphoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Ixazomib Rollover Study [Phase 2]
A Phase 2 Ixazomib rollover study has completed, with results posted on 2025-03-12. The study encompassed multiple myeloma, lymphoma, and am…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
This completed clinical trial evaluated myeloablative hematopoietic progenitor cell transplantation in pediatric patients with chronic myelo…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors [NA]
Completed update for the BurnAlong Pilot Study evaluating a program for adolescent and young adult cancer survivors. The study spans multipl…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: IIT2020-20-SHIRAZIP-WALK: Nature Walks [NA]
The IIT2020-20-SHIRAZIP-WALK trial sponsored by Cedars-Sinai Medical Center has completed, studying breast cancer and several hematologic ma…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer [Phase 1]
A Phase 1 study of ALRN-6924, a dual MDM2/MDMX inhibitor, in pediatric cancers has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer [NA]
A pilot study from Memorial Sloan Kettering Cancer Center evaluating geriatric-specific interventions to improve quality of life in elderly …
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma [Phase 2]
Phase 2 trial results for BV-CHEP chemotherapy in adults with adult T-cell leukemia/lymphoma and lymphoma have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction [Phase 1]
Phase 1 clinical trial update of romidepsin for patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with liver dysfunction…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma [Phase 1]
This Phase 1 study evaluated the safety, pharmacokinetics, and pharmacodynamics of JNJ-42756493 in adults with advanced or refractory solid …
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating safety and preliminary activity of KT-253 in adults with high-grade myeloid malignancies, acute lymphoblas…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory Lymphoma [Phase 2]
Phase 2 study of tazemetostat in combination with HMPL-689 for relapsed/refractory lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: A Study of People With CD30 Positive Lymphoma in China
Takeda-sponsored clinical trial in China evaluating CD30-positive lymphoma has completed.